SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · DOV

DOVER REPORTS THIRD QUARTER 2026 RESULTS

DOVER Corp · Filed · SEC Form 8-K, Item 2.02

DOVER Corp company page Original on SEC.gov ↗

Revenue $2.2 billion +8% vs a year ago
EPS $2.50 +14% vs a year ago
Guidance issuedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue increased 8% year on year to $2.2 billion, and EPS climbed 14% to $2.50. Growth in both sales and earnings is the combination investors usually look for first. The company issued new guidance, which gives a first marker for expectations in the periods ahead.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$2.2 billion +8% vs a year ago

…ded September 30, 2026, Dover generated revenue of $2.2 billion, an increase of 8% (+7% organic).…
EPS

$2.50 +14% vs a year ago

…increased by 11%, and GAAP diluted EPS from continuing operations of $2.50 was up 14%.…
Guidance

Guidance issued

…FULL YEAR 2026 GUIDANCE: In 2026, Dover expects to generate GAAP EPS in the range of $8.93 to $9.08 (adjusted EPS of $10.60 to $10.75), based on full year revenue growth of 7% to 8% (organi…

Read the original press release on SEC.gov ↗ Filing index ↗

Trend: last 1 reports

All releases →

Revenue growth (YoY)

EPS growth (YoY)

Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.